The first-of-its-kind multidisciplinary Atrial Fibrillation [AFiB] Symposium in Kuwait called for a focused dialogue and the need to augment additional resources to support the education and detection campaigns on the life-threatening Atrial Fibrillation condition that impacts nearly 40 million people globally.¹

The symposium, organized at The Regency Convention Center Kuwait City represents a collaboration between Dr. Samah AlKharji, Heart Rhythm Specialist Head of Department of Cardiology at Dabbous Cardiac Center, Adan Hospital, and Biosense Webster ME – part of Johnson & Johnson MedTech Family of Companies, which brought together over 75 participants representing different cardiac specialties to discuss ways to tackle AFiB.